EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

mTORC1 restricts TFE3 activity by auto-regulating its presence on lysosomes

Susan Zwakenberg, Denise Westland, Robert M van Es, Holger Rehmann, Jasper Anink, Jolita Ciapaite, Marjolein Bosma, Ellen Stelloo, Nalan Liv, Paula Sobrevals Alcaraz, Nanda M Verhoeven-Duif, Judith J M Jans und 3 weitere

Molecular Cell · 2024

DOI: 10.1016/j.molcel.2024.10.009 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Cell, 2024. Verfasst von Susan Zwakenberg und 14 weiteren Autor:innen. Beteiligte Einrichtung: Center for Molecular Medicine, University Medical Center Utrecht, Universiteitsweg 100, 3584 CG Utrecht, the Netherlands; Oncode Institute, Utrecht, …. Hauptthemen laut MEDLINE: Lysosomes, Mechanistic Target of Rapamycin Complex 1, Basic Helix-Loop-Helix Leucine Zipper Transcription Factors, TOR Serine-Threonine Kinases. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 81 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: H2020 European Institute of Innovation and Technology, ZonMw, TSC Fund Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

To stimulate cell growth, the protein kinase complex mTORC1 requires intracellular amino acids for activation. Amino-acid sufficiency is relayed to mTORC1 by Rag GTPases on lysosomes, where growth factor signaling enhances mTORC1 activity via the GTPase Rheb. In the absence of amino acids, GATOR1 inactivates the Rags, resulting in lysosomal detachment and inactivation of mTORC1. We demonstrate that in human cells, the release of mTORC1 from lysosomes depends on its kinase activity. In accordance with a negative feedback mechanism, activated mTOR mutants display low lysosome occupancy, causing hypo-phosphorylation and nuclear localization of the lysosomal substrate TFE3. Surprisingly, mTORC1 activated by Rheb does not increase the cytoplasmic/lysosomal ratio of mTORC1, indicating the existence of mTORC1 pools with distinct substrate specificity. Dysregulation of either pool results in aberrant TFE3 activity and may explain nuclear accumulation of TFE3 in epileptogenic malformations in focal cortical dysplasia type II (FCD II) and tuberous sclerosis (TSC).

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LysosomesMechanistic Target of Rapamycin Complex 1Basic Helix-Loop-Helix Leucine Zipper Transcription FactorsTOR Serine-Threonine KinasesRas Homolog Enriched in Brain ProteinMonomeric GTP-Binding ProteinsMultiprotein ComplexesHumansHEK293 CellsPhosphorylationSignal TransductionCell NucleusNeuropeptidesActive Transport, Cell NucleusMutation

Stichwörter der Autor:innen

FCD IIbNPRL2Rag GTPasesRhebTFE3TSCamino acidslysosomesmTORC1

Substanzen

Mechanistic Target of Rapamycin Complex 1TFE3 protein, humanBasic Helix-Loop-Helix Leucine Zipper Transcription FactorsTOR Serine-Threonine KinasesRas Homolog Enriched in Brain ProteinMonomeric GTP-Binding ProteinsMultiprotein ComplexesRHEB protein, humanNeuropeptides

Autor:innen und Institutionen

  • Center for Molecular Medicine, University Medical Center Utrecht, Universiteitsweg 100, 3584 CG Utrecht, the Netherlands; Oncode Institute, Utrecht, the Netherlands.
  • Center for Molecular Medicine, University Medical Center Utrecht, Universiteitsweg 100, 3584 CG Utrecht, the Netherlands.
  • Department of Energy and Life Science, Flensburg University of Applied Sciences, Flensburg, Germany.
  • Department of (Neuro)Pathology, Amsterdam UMC, University of Amsterdam, Amsterdam Neuroscience, Amsterdam, the Netherlands.
  • Department of Genetics, Section Metabolic Diagnostics, University Medical Center Utrecht, 3584 EA Utrecht, the Netherlands.
  • Department of (Neuro)Pathology, Amsterdam UMC, University of Amsterdam, Amsterdam Neuroscience, Amsterdam, the Netherlands; Stichting Epilepsie Instellingen Nederland (SEIN), Heemstede, the Netherlands.

Förderung

  • H2020 European Institute of Innovation and Technology
  • ZonMw
  • TSC Fund Foundation
  • Nederlandse Organisatie voor Wetenschappelijk Onderzoek

Zitieren

APA

Zwakenberg, S., Westland, D., van Es, R. M., Rehmann, H., Anink, J., Ciapaite, J., Bosma, M., Stelloo, E., Liv, N., Sobrevals Alcaraz, P., Verhoeven-Duif, N. M., Jans, J. J. M., Vos, H. R., Aronica, E., & Zwartkruis, F. J. T. (2024). mTORC1 restricts TFE3 activity by auto-regulating its presence on lysosomes. Molecular Cell. https://doi.org/10.1016/j.molcel.2024.10.009

Vancouver

Zwakenberg S, Westland D, van Es RM, Rehmann H, Anink J, Ciapaite J, et al. mTORC1 restricts TFE3 activity by auto-regulating its presence on lysosomes. Molecular Cell. 2024. doi:10.1016/j.molcel.2024.10.009

BibTeX
@article{Zwakenberg2024,
  author = {Zwakenberg, Susan and Westland, Denise and van Es, Robert M and Rehmann, Holger and Anink, Jasper and Ciapaite, Jolita and Bosma, Marjolein and Stelloo, Ellen and Liv, Nalan and Sobrevals Alcaraz, Paula and Verhoeven-Duif, Nanda M and Jans, Judith J M and Vos, Harmjan R and Aronica, Eleonora and Zwartkruis, Fried J T},
  title = {mTORC1 restricts TFE3 activity by auto-regulating its presence on lysosomes},
  journal = {Molecular Cell},
  year = {2024},
  doi = {10.1016/j.molcel.2024.10.009}
}
Kostenlos starten →